MedTrace Logo

3-Month Trial Observation of A1c Change

NCT01415271 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-08-13

No results posted yet for this study

Summary

The incidence of type 2 diabetes in long term care facilities has been approximated at 25% with barriers to treatment including untimely access to a specialist and improper/poor adherence to insulin regimes. This 3 month trial will investigate the efficacy of improving overall glycemic control by using an internet blood glucose reporting system to facilitate bi-weekly consultations between long term care facility patients with type 2 diabetes and an endocrinologist.

Conditions

Interventions

OTHER

Internet Communication

bi-weekly communication of blood sugars using an internet platform between patients with type 2 diabetes and an endocrinologist

Sponsors & Collaborators

  • Endocrine Research Society

    lead OTHER

Principal Investigators

  • Hugh Tildesley · Providence Health Care, University of British Columbia

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01415271 on ClinicalTrials.gov